医学
淋巴结切除术
癌症
前哨淋巴结
外科
哨兵节点
淋巴结
疾病
阶段(地层学)
普通外科
内科学
乳腺癌
古生物学
生物
作者
George Z. Li,Gerard M. Doherty,Jiping Wang
出处
期刊:JAMA Surgery
[American Medical Association]
日期:2022-03-23
卷期号:157 (5): 446-446
被引量:129
标识
DOI:10.1001/jamasurg.2022.0182
摘要
Surgery plays a critical role in the management of all stages of gastric cancer.For patients with early gastric cancer and low risk of lymph node metastasis, endoscopic therapy or surgery alone is potentially curative. Novel techniques, such as sentinel lymph node biopsy, may allow for greater use of stomach-sparing procedures that could improve quality of life without compromising oncologic outcomes; however, experience with these techniques is rare outside of East Asia, and studies of long-term outcomes are still ongoing. Patients with later-stage localized gastric cancer benefit from more extensive lymphadenectomy and multimodality therapy, as they are at risk for nodal and distant metastases. There have been recent advances in chemotherapy that have led to improved survival, but the optimal sequencing of multimodality therapy is still being investigated. Better systemic therapy may also increase the role of surgery for patients with oligometastatic disease. There are ongoing studies examining the efficacy of peritoneal-directed therapies in both patients with low-volume peritoneal disease and patients at high risk of peritoneal recurrence.The management of gastric cancer continues to evolve. Surgeons should be aware of novel surgical approaches currently under investigation as well as how surgery fits into the contemporary multidisciplinary approach to this disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI